Author:
Kajornsrichon Wachira,Chaisaingmongkol Jittiporn,Pomyen Yotsawat,Tit-oon Phanthakarn,Wang Xin Wei,Ruchirawat Mathuros,Fuangthong Mayuree
Funder
Chulabhorn Graduate Scholarship
Ministry of Higher Education, Science, Research and Innovation, and Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute
Intramural Program of the Center for Cancer Research, National Cancer Institute
Center of Excellence on Environmental Health and Toxicology (EHT), OPS
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Chung, T. & Park, Y. N. Up-to-date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma. Front. Med. 9, 857140. https://doi.org/10.3389/fmed.2022.857140 (2022).
2. Treeprasertsuk, S. et al. A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: A nationwide database study. BMC Gastroenterol. 17, 3. https://doi.org/10.1186/s12876-016-0565-6 (2017).
3. Bridgewater, J. et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J. Hepatol. 60, 1268–1289. https://doi.org/10.1016/j.jhep.2014.01.021 (2014).
4. Howlader, N. et al. SEER cancer statistics review, 1975–2017, based on November 2019 SEER data submission, Section: 14 Liver and bile duct, Table 14.18 (Surveillance Research Program, National Cancer Institute, 2020). https://seer.cancer.gov/csr/1975_2017/
5. Razumilava, N. & Gores, G. J. Classification, diagnosis, and management of cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 11, 13-21.e11. https://doi.org/10.1016/j.cgh.2012.09.009 (2013).